| Course | NR 567 Advanced Pharmacology for the Adult Gerontology Acute Care Nurse Practitioner |
|---|---|
| Week | 1 |
| Paper type | Discussion post with two replies |
| Length | About 600 words |
| Format | Discussion post with APA 7 citations |
| School | Chamberlain University |
| Program | MSN, Adult-Gerontology Acute Care NP (AGACNP) |
| Updated | October 2026 |
Free sample paper for NR 567 Week 1
Week 1 Discussion: Initial Post
Seizing in the Back of an Ambulance With No Vein: Why the Intramuscular Route Wins the Race Against the Clock in Status Epilepticus
Initial Post
The patient for this post is a composite: a 58-year-old with a known seizure disorder who has been convulsing for eight minutes when the paramedics arrive at a farm workshop. There is no intravenous access, the patient is sweating and rigid, and every attempt at a vein is failing because the limbs keep moving. Convulsive status epilepticus is defined operationally as five minutes or more of continuous seizure, and each minute that passes makes the seizure harder to stop and raises the risk of neuronal injury, so the clock is the main clinical fact here.
The route follows from that clock. The textbook answer is intravenous lorazepam, but intravenous lorazepam only works once a line is in, and in a convulsing patient that can take many minutes. Intramuscular midazolam needs no line. In a randomized prehospital trial, intramuscular midazolam 10 mg (for adults over 40 kg) was at least as effective as intravenous lorazepam: seizures had stopped on arrival at the emergency department in 73.4% of the midazolam group and 63.4% of the lorazepam group (Silbergleit et al., 2012). The key reason was time. Once given, intravenous lorazepam acted faster, but because the intramuscular injection could be given almost immediately, the total time from paramedic arrival to seizure control was shorter with midazolam. That is the gap between the order and the first measurable change, and it is the gap this patient cannot afford.
Guidelines reflect this: intramuscular midazolam, intravenous lorazepam and intravenous diazepam are all first-line options in the initial phase, and the choice depends on what access exists in the first minutes (Glauser et al., 2016). For this patient, the decision is intramuscular midazolam 10 mg into the lateral thigh, now.
Offset matters too. Midazolam acts quickly but is short-acting, so a seizure can recur within an hour, which is why second-line therapy must be ready if seizures continue at 20 minutes or recur. The wrong call here would be to keep trying for a vein while the seizure continues, or to give a smaller dose because of worry about breathing. Respiratory depression is more often caused by the prolonged seizure itself than by the benzodiazepine, and undertreatment is the more common error. The crew must be ready with a bag-valve mask, oxygen and suction.
Question for the group: if this same patient had end-stage liver disease, would that change your choice of benzodiazepine or your dose, given how midazolam is metabolized?
Reply to Renee
Renee, your patient with a massive pulmonary embolism is a strong example, and I agree that the intravenous route is the only one that makes sense when you need thrombolysis within minutes. One addition: you described alteplase's onset but not its offset. If that patient needed an emergency procedure an hour later, how long would the bleeding risk last, and what would you have ready? Naming the offset would complete the clock you started.
Reply to Victor
Victor, your example of inhaled albuterol in a severe asthma attack shows well why a route that keeps the drug in the chest is preferred. I wonder how your plan would change if the patient were too tight to move air at all. Would you add an intramuscular or intravenous route, and which agent would you choose for that second line? That question puts another organ, the lung that cannot deliver the inhaled dose, into your argument.
References
Glauser, T., Shinnar, S., Gloss, D., Alldredge, B., Arya, R., Bainbridge, J., Bare, M., Bleck, T., Dodson, W. E., Garrity, L., Jagoda, A., Lowenstein, D., Pellock, J., Riviello, J., Sloan, E., & Treiman, D. M. (2016). Evidence-based guideline: Treatment of convulsive status epilepticus in children and adults: Report of the Guideline Committee of the American Epilepsy Society. Epilepsy Currents, 16(1), 48-61. https://doi.org/10.5698/1535-7597-16.1.48
Silbergleit, R., Durkalski, V., Lowenstein, D., Conwit, R., Pancioli, A., Palesch, Y., & Barsan, W. (2012). Intramuscular versus intravenous therapy for prehospital status epilepticus. New England Journal of Medicine, 366(7), 591-600. https://doi.org/10.1056/NEJMoa1107494
The Chamberlain NR 567 Week 1 instructions
The first discussion in this acute care pharmacology course usually asks what changes when a drug has to work immediately. Expect the prompt to ask for a patient, a route, the time to effect and the risks of that choice. Open with a patient who cannot wait, and let that fact decide the route. Defend the route rather than assuming it, for example by explaining why no vein, a failing gut or a lung that needs local delivery points one way. Give the time to effect as a number, with a source. Name the offset and what goes wrong if the drug wears off early or the wrong choice is made. End with a question that changes an organ, and reply by extending a classmate's clock.
How this NR 567 Week 1 example is built
The sample opens with a composite 58-year-old convulsing in a farm workshop with no intravenous access and explains why five minutes defines status epilepticus. The route section contrasts intravenous lorazepam, which needs a line, with intramuscular midazolam, which does not, and cites the trial showing faster overall seizure control with the injection. A guideline sentence confirms both as first-line choices. The dose, 10 mg into the thigh, is written. A paragraph on offset explains why second-line drugs must be ready and why undertreatment, not respiratory depression, is the more common error. The question asks about liver disease. Replies ask Renee about alteplase offset and Victor about a chest too tight for inhaled albuterol.
Reading the NR 567 Week 1 grading rubric
Points for this opening post usually depend on a patient whose urgency shapes the decision, a defended route, a numeric time to effect, attention to offset and risk, and replies that add to a classmate's reasoning. An encyclopedia entry on a drug class, correct but without a patient or a clock, tends to land in the middle, so this sample leads with the patient and the missing vein. Citing trial percentages turns time to effect into evidence. Naming the wrong call shows judgment about what can go wrong. The question about hepatic metabolism moves the discussion to another organ, which the brief rewards. Replies about offset and a failed inhaled route extend peers' arguments rather than agreeing. APA 7 citations support the clinical claims.
NR 567 Week 1 help: mistakes that cost points
The most costly version of this post is the drug summary, accurate on mechanism and adverse effects but with no patient and no time. Another common gap is a route stated without any argument, which reads as habit. Some posts give onset in vague words rather than minutes. Others ignore offset entirely, though a short-acting drug in status epilepticus is exactly where offset matters. Replies that only praise the original add nothing. Start with a patient who cannot wait, defend the route, give the clock in numbers and name the wrong call. A version built on another emergency, such as anaphylaxis or a pulmonary embolism, can be drafted from the case you describe.
Get a NR 567 Week 1 example written to your instructions
Send the Week 1 prompt exactly as your classroom words it, along with the drug or the presentation you want the post built on, and we write a custom example against it. The first one is free, it comes back inside 24-48h, and reply drafts are included if your section grades those separately.
More NR 567 papers and AGACNP samples
- NR 567 Week 2: Critical Illness Dosing Brief
- NR 567 Week 3: Titration Plan
- NR 567 Week 4: Vasoactive Support Write-up
- NR 567 Week 5: Sedation and Analgesia Plan
- NR 567 Week 6: Empiric Antimicrobial Rationale
- NR 567 Week 7: Anticoagulation Case Analysis
- NR 567 Week 8: De-escalation Plan
NR 567 Week 1 questions, answered
Is this the same discussion as the one in the primary care pharmacology course?
No, and the boards read differently. A primary care post can take a week to learn whether it worked, so it argues about the long run choice between agents. This one is written where the answer arrives in minutes and the wrong answer has to be reversible, so route, onset and offset carry the marks that class and mechanism carry elsewhere.
How much pharmacology should actually appear in the post?
Enough to justify the timing and no more. The finished example uses mechanism the way a witness uses a fact, in one clause, because the drug reaches its site quickly or because it is cleared by an organ that still works. Long mechanistic passages read as material copied out of a lecture rather than as a decision somebody made at a bedside.
Can you write the replies as well as the opening post?
Yes, and they are worth asking for. A reply that scores brings in a second patient in whom the route would have to change, then asks what the original writer would do about it. Replies that praise the post and repeat its conclusion are the cheapest points on the board to lose, and they are lost every week.
Where can I find a free NR 567 Week 1 sample paper?
The status epilepticus post above, with its route argument and replies to Renee and Victor, is the full NR 567 Week 1 sample. Another emergency can be argued the same way from your own case.
Why is intramuscular midazolam used in the NR 567 Week 1 example?
Because the patient has no intravenous access. In a prehospital trial, giving midazolam into muscle controlled seizures sooner overall than waiting to place a line for lorazepam.